Continuous education is key to mutual business success. DiaSys is aware that it is a challenge to stay in touch in times of the COVID-19 pandemic.
Nevertheless, a virtual reagent training took place on three subsequent days in the first week of August 2021. Mostly, partners from South America were invited to attend. We counted approximately 50 participants per session.
Beside a general introduction on DiaSys’ product lines and concept, a total of 13 sessions offered fundamental knowledge on the following topics:
• Lipid diagnostics
• Performance criteria – Why we are better
• DiaSys quality: Calibrators and controls
• Principles of immunoturbidimetry
• Renal diagnostics
• Thromboembolic events (focus on D-Dimer)
• Inflammatory markers (focus on PCT and CRP)
• Specialties in the assay portfolio (e.g. HCY and NEFA)
• Diabetes, and
• COVID-19 antibody test SARS-CoV-2 UTAB FS
The presentation slides were presented in Spanish and commented in English by Ms. Irene Delseith-Hermsdorf, Head of Global Marketing and Product Management, Ms. Isabella Wieland, Strategic Product Manager Reagents, Mr. David Ehlers, Strategic Product Manager Systems, and Mr. Roland Heyer, Area Business Director.
The main goal - to highlight not only the technical aspects of DiaSys product lines but as well the marketing and unique selling features, and thus, to create more awareness of the excellent quality of DiaSys portfolio - has been achieved. The feedback given to us was that the training was very well received. We hope to have motivated our partners to convert all this information into successful sales figures.
Even if we strive to expand this virtual format even further in the future, we are of course looking forward to the moment when we will be able to welcome you personally again at the Holzheim headquarters.